The popularity of Converus’ EyeDetect technology continues to grow. In February, company representatives spoke to dozens of potential customers in Mexico City and Panama City.
LEHI, Utah – March 9, 2015 – Converus (www.converus.com) Science Team Member Dr. David Raskin visited Mexico City and Panama City last month to speak to various audiences about the current lie detection technologies on the market. Converus President and CEO Todd Mickelsen accompanied him.
Dr. Raskin’s presentation, titled “Today’s Lie Detection Technologies,” covered the polygraph, MRI, electroencephalogram, intuition, integrity and personality tests, and EyeDetect. EyeDetect, by Converus, is the world’s first lie detector that measures deception based on eye behaviors.
“The eyes exhibit involuntary changes when lying,” said Dr. Raskin. “Liars, concerned about being believed, often come across as helpful and truthful in an interview and put more effort into impressing their interviewer.”
On the morning of Feb. 24, Dr. Raskin and Mickelsen spoke to 80 potential customers in Mexico City at the Uny-II office, a Converus service provider. Also attending were many of the Converus authorized Service Partners. That evening, Dr. Raskin also addressed a group of polygraph examiners. Because of Dr. Raskin’s well-known work in the lie detection industry over the years, many attendees requested to have their photo taken with him.
Dr. Raskin pointed out the polygraph is 74-94 percent accurate for event-specific questions and 65-85 percent accurate for pre-employment and periodic employee screening. However, EyeDetect is 85 percent accurate and has the additional advantages of being nonintrusive, faster and less expensive.
“Because of all the advantages our technology offers over other lie detection technologies, Converus not only has many new customers in Mexico, but also the interest from potential customers continues to grow,” said Mickelsen, who shared EyeDetect case studies and the potential return on investment for employers who use this new technology for screening job candidates and evaluating current employees.
On Feb. 26 in Panama City, Dr. Raskin and Mickelsen spoke at the Hard Rock Hotel to 75 perspective customers. This event was co-sponsored by EyeScan, an authorized Converus service provider in Panama City.
Dr. Raskin has served on the faculties of UCLA, Michigan State and the University of Utah. He’s authored more than 150 scientific articles, chapters, books and reports. Previously, Dr. Raskin worked with the National Institute of Justice, National Science Foundation, Department of Defense, Central Intelligence Agency, U.S. Secret Service and National Institute of Mental Health on the topic of lie detection. He’s consulted and trained many U.S federal agencies and foreign governments. Dr. Raskin and his colleague, Dr. John Kircher, are recognized worldwide as leaders in the research and development of polygraph methods. They introduced the first computerized polygraph in1991. Dr. Raskin earned his Ph.D. in psychology from UCLA.
Mickelsen has more than 25 years of high-tech senior management experience in business development, sales and product management at start-ups and established software giants, including Microsoft. Prior to joining Converus, he was director of product management at Ancestry.com, responsible for the definition and delivery of a new family history software platform. As a co-founder of NextPage, a provider of search and content networking software, he also served as the managing director of NextPage Europe Ltd., overseeing the EMEA business out of the London office. As VP of Business Development at FAST Search, a leader in enterprise search technology, he helped grow the company to more than $100 million in revenue — leading to an acquisition by Microsoft for $1.2 billion. At Microsoft, Mickelsen provided product direction for Microsoft’s enterprise search products. He holds a Bachelor of Science in marketing and business from Brigham Young University.
For more information, visit www.converus.com.
# # #
Converus (“with truth”) is committed to providing trustworthy credibility assessment solutions. Its flagship product, EyeDetect® — a product first conceived in 2002 — is the first ocular-motor deception detection solution. It’s an accurate, cost-effective, efficient, secure and nonintrusive method that detects deception in 30 minutes by analyzing eye behavior. The same scientists credited with computerizing the polygraph in 1991 developed EyeDetect. It’s a new way for organizations to manage risk and ensure workplace integrity, and for law enforcement agencies and governments to detect deception. Ultimately, it helps protect countries, corporations and communities from corruption, fraud and threats. The company is headquartered in Lehi, Utah, USA. For more information, visit www.converus.com.
Press Contact: Jeff Pizzino, APR / +1 480.606.8292